Data / Drug companies / Little Pharma, Inc.
Little Pharma, Inc.: 25 products in the FDA NDC directory, labeler code 72559
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Little Pharma, Inc. (labeler code 72559) lists 25 products in the FDA National Drug Code Directory, covering 18 finished drugs by generic name. By type: 25 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 15, 2026.
The request: Watch Little Pharma, Inc. (FDA labeler code 72559): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 72559
- Products in commercial distribution
- 25
- Packages
- 46
- Finished drugs by generic name
- 18
- Prescription products
- 0
- Over the counter products
- 25
- Flagged as original packager
- 22 of 22 products that carry the flag
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- June 26, 2019
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 16 | 64% |
| Over the counter monograph drugs | 9 | 36% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 25 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Simethicone | 3 | 86 |
| Lidocaine | 3 | 216 |
| Guaifenesin | 2 | 123 |
| Fexofenadine hydrochloride 180 mg | 2 | 1 |
| Levocetirizine dihydrochloride 5 mg | 2 | 1 |
| Famotidine 20 mg | 1 | 2 |
| Famotidine | 1 | 138 |
| Lidocaine 4% patch | 1 | 1 |
| Diclofenac sodium | 1 | 109 |
| Loratadine 10 mg | 1 | 1 |
| Lidocaine spray | 1 | 1 |
| Loratadine 5 mg chewable tablets | 1 | 1 |
| Terbinafine hydrochloride | 1 | 39 |
| Esomeprazole magnesium | 1 | 77 |
| Cetirizine hydrochloride | 1 | 119 |
| Adapalene | 1 | 34 |
| Lidocaine 5% | 1 | 23 |
| Omeprazole | 1 | 106 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 7 | 28% |
| Cream | 4 | 16% |
| Capsule, liquid filled | 3 | 12% |
| Tablet, extended release | 2 | 8% |
| Patch | 2 | 8% |
| Gel | 2 | 8% |
| Aerosol, spray | 1 | 4% |
| Tablet, chewable | 1 | 4% |
| Capsule, delayed release | 1 | 4% |
| Tablet, coated | 1 | 4% |
| Tablet, delayed release | 1 | 4% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Curist Gas Relief | 72559-042 | Capsule, liquid filled | Over the counter monograph drugs | October 15, 2026 |
| Curist lidocaine can | 72559-023 | Aerosol, spray | Over the counter monograph drugs | October 9, 2026 |
| Curist Gas Relief | 72559-041 | Capsule, liquid filled | Over the counter monograph drugs | July 31, 2025 |
| Famotidine | 72559-038 | Tablet | Generic drugs (ANDA) | May 15, 2025 |
| Curist Hemorrhoid Fissure Relief | 72559-037 | Cream | Over the counter monograph drugs | May 1, 2025 |
| Curist Antifungal Relief | 72559-035 | Cream | Generic drugs (ANDA) | December 10, 2024 |
| Curist Childrens Allergy Relief | 72559-031 | Tablet, chewable | Generic drugs (ANDA) | June 12, 2024 |
| Curist Lidocaine Patch | 72559-026 | Patch | Over the counter monograph drugs | June 12, 2024 |
| Curist Acid Relief | 72559-032 | Tablet | Generic drugs (ANDA) | January 31, 2024 |
| Curist Allergy Relief | 72559-033 | Tablet | Generic drugs (ANDA) | December 12, 2023 |
| Curist Hives Relief | 72559-028 | Tablet | Generic drugs (ANDA) | September 7, 2023 |
| Curist Allergy Relief | 72559-027 | Tablet | Generic drugs (ANDA) | March 30, 2023 |
| Curist Lidocaine Relief | 72559-024 | Cream | Over the counter monograph drugs | February 23, 2023 |
| Curist Allergy Relief | 72559-021 | Tablet | Generic drugs (ANDA) | January 24, 2023 |
| Curist Allergy Relief | 72559-021 | Tablet | Generic drugs (ANDA) | January 24, 2023 |
| Curist Arthritis Relief | 72559-020 | Gel | Generic drugs (ANDA) | August 15, 2022 |
| Curist Acne Relief | 72559-015 | Gel | Generic drugs (ANDA) | August 15, 2022 |
| Curist Gas Relief Maximum Strength | 72559-019 | Capsule, liquid filled | Over the counter monograph drugs | April 7, 2022 |
| Curist Mucus Relief | 72559-017 | Tablet, extended release | Generic drugs (ANDA) | February 21, 2022 |
| Curist Lidocaine Patch Maximum Strength | 72559-025 | Patch | Over the counter monograph drugs | August 4, 2021 |
| Curist Mucus Relief Maximum Strength | 72559-013 | Tablet, extended release | Generic drugs (ANDA) | July 23, 2021 |
| Curist Lidocaine Numbing Relief | 72559-012 | Cream | Over the counter monograph drugs | April 14, 2021 |
| Esomeprazole Magnesium | 72559-011 | Capsule, delayed release | Generic drugs (ANDA) | March 23, 2021 |
| Omeprazole | 72559-014 | Tablet, delayed release | Generic drugs (ANDA) | July 15, 2020 |
| Curist Allergy Relief | 72559-003 | Tablet, coated | Generic drugs (ANDA) | June 26, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.